APLS APELLIS PHARMACEUTICALS INC
FollowCOM (common)
Filings received so far for Q3 2024: 4 13F filers report a position in APLS shares at 2024-09-30. The quarter is not complete: its 13F deadline is 2024-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2024
Filers in the available 13F reports with a share position at 2024-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| BARCLAYS PLCin group BARCLAYS PLC | 255,897 | $7.38M | <0.01% | +39,019 | 13F-HR/ATimelineGroup |
| ALGERT GLOBAL LLC | 82,411 | $2.38M | 0.06% | -41,217 | 13F-HR/ATimeline |
| Leonteq Securities AG | 3,178 | $91.7K | 0.01% | +2,017 | 13F-HRTimeline |
| DANSKE BANK A/S | 2,100 | $60.6K | <0.01% | new | 13F-HRTimeline |